Skip to main content
. 2012 Oct 31;7(10):e47476. doi: 10.1371/journal.pone.0047476

Figure 3. Western blot validation of four candidate cholangiocarcinoma biomarkers in individual bile samples.

Figure 3

Western blotting (top) and quantification (bottom) of candidate biomarker expression in equal volumes of individual bile samples from 10 cholangitis patients (benign) and 19 cholangiocarcinoma (CC) patients. (A) PGAM-1; (B) PDIA3; (C) HSPD1 (D) and SSP411.